Deutsch English Français

Contact

EP1498411

European procedure

Quick help

Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...

News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...

Extract from the Register of European Patents

EP About this file: EP1498411

EP1498411 - DIKETOHYDRAZINE DERIVATIVE COMPOUNDS AND DRUGS CONTAINING THE COMPOUNDS AS THE ACTIVE INGREDIENT [Right-click to bookmark this link]
Status	No opposition filed within time limit Status updated on 22.11.2013 Database last updated on 02.07.2024
Most recent event Tooltip	29.11.2013	Lapse of the patent in a contracting state New state(s): MC	published on 01.01.2014 [2014/01]
Applicant(s)	For all designated states ONO PHARMACEUTICAL CO., LTD. 1-5, Doshomachi 2-chome Chuo-ku Osaka-shi, Osaka 541-8526 / JP
	[2013/03]
Former [2005/03]	For all designated states ONO PHARMACEUTICAL CO., LTD. 1-5, Doshomachi 2-chome, Chuo-ku Osaka-shi, Osaka 541-8526 / JP
Inventor(s)	01 / HATAYAMA, Akira, c/o Ono Pharmaceutical Co. Ltd. 1-1, Sakurai 3-chome Shimamoto-cho Mishima-gun, Osaka 618-8585 / JP
	02 / TSURUTA, Hiroshi, c/o Ono Pharmaceutical Co. Ltd. 1-1, Sakurai 3-chome Shimamoto-cho Mishima-gun, Osaka 618-8585 / JP
	03 / OCHI, Yasuo, c/o Ono Pharmaceutical Co. Ltd. 1-1, Sakurai 3-chome Shimamoto-cho Mishima-gun, Osaka 618-8585 / JP
	04 / IMAWAKA, Haruo, c/o Ono Pharmaceutical Co. Ltd. 1-1, Sakurai 3-chome Shimamoto-cho Mishima-gun, Osaka 618-8585 / JP
	05 / OHMOTO, Kazuyuki c/o Ono Pharmaceutical Co. Ltd. 1-1, Sakurai 3-chome Shimamoto-cho Mishima-gun, Osaka 618-8585 / JP
	[2012/51]
Former [2005/03]	01 / HATAYAMA, Akira, c/o Ono Pharmaceutical Co. Ltd. 1-1, Sakurai 3-chome, Shimoto-cho Mishima-gun, Osaka 618-8585 / JP
	02 / TSURUTA, Hiroshi, c/o Ono Pharmaceutical Co. Ltd. 1-1, Sakurai 3-chome, Shimamoto-cho Mishima-gun, Osaka 618-8585 / JP
	03 / OCHI, Yasuo, c/o Ono Pharmaceutical Co. Ltd. 1-1, Sakurai 3-chome, Shimamoto-cho Mishima-gun, Osaka 618-8585 / JP
	04 / IMAWAKA, Haruo, c/o Ono Pharmaceutical Co. Ltd. 1-1, Sakurai 3-chome, Shimamoto-cho Mishima-gun, Osaka 618-8585 / JP
	05 / OHMOTO, Kazuyuki c/o Ono Pharmaceutical Co. Ltd. 1-1, Sakurai 3-chome, Shimamoto-cho Mishima-gun, Osaka 618-8585 / JP
Representative(s)	McCluskie, Gail Wilson J A Kemp 14 South Square Gray's Inn London WC1R 5JJ / GB
	[2013/03]
Former [2005/03]	McCluskie, Gail Wilson J.A. Kemp & Co., 14 South Square, Gray's Inn London WC1R 5JJ / GB
Application number, filing date	03723188.3	24.04.2003
	[2005/03]
	WO2003JP05252
Priority number, date	JP20020123796	25.04.2002 Original published format: JP 2002123796
	[2005/03]
Filing language	JA
Procedural language	EN
Publication	Type:	A1 Application with search report
	No.:	WO03091202
	Date:	06.11.2003
	Language:	EN
	[2003/45]
	Type:	A1 Application with search report
	No.:	EP1498411
	Date:	19.01.2005
	Language:	EN
	The application published by WIPO in one of the EPO official languages on 06.11.2003 takes the place of the publication of the European patent application.
	[2005/03]
	Type:	B1 Patent specification
	No.:	EP1498411
	Date:	16.01.2013
	Language:	EN
	[2013/03]
	Type:	B9 Corrected patent specification
	No.:	EP1498411
	Date:	04.12.2013
	[2013/49]
Search report(s)	International search report - published on:	JP	06.11.2003
	(Supplementary) European search report - dispatched on:	EP	14.10.2005
Classification	IPC:	C07C243/24, C07C251/76, C07C251/84, C07C251/86, C07D207/22, C07D207/408, C07D207/50, C07D211/26, C07D213/53, C07D231/08, C07D233/32, C07D263/26, C07D275/02, C07D277/18, C07D307/52, C07D309/04, C07D309/06, C07D405/12, C07D413/12, C07D417/12, C07D487/04	[2005/03]
	CPC:	C07D209/48 (EP,US); C07D417/12 (EP,KR,US); A61K31/16 (EP,US); A61K31/165 (EP,US); A61K31/341 (EP,US); A61K31/351 (EP,US); (+) A61K31/40 (EP,US); A61K31/4025 (EP,US); A61K31/4035 (EP,US); A61K31/4152 (EP,US); A61K31/4166 (EP,US); A61K31/4168 (EP,US); A61K31/421 (EP,US); A61K31/423 (EP,US); A61K31/425 (EP,US); A61K31/426 (EP,US); A61K31/427 (EP,US); A61K31/428 (EP,US); A61K31/429 (EP,US); A61P1/16 (EP); A61P11/00 (EP); A61P19/00 (EP); A61P19/02 (EP); A61P19/08 (EP); A61P19/10 (EP); A61P25/00 (EP); A61P25/28 (EP); A61P29/00 (EP); A61P3/00 (EP); A61P3/14 (EP); A61P31/00 (EP); A61P31/18 (EP); A61P35/00 (EP); A61P37/00 (EP); A61P43/00 (EP); A61P5/00 (EP); A61P7/00 (EP); A61P9/00 (EP); A61P9/10 (EP); C07C243/34 (EP,US); C07C251/76 (EP,US); C07C251/84 (EP,US); C07C251/86 (EP,US); C07D207/22 (EP,KR,US); C07D207/50 (EP,US); C07D209/46 (EP,US); C07D211/28 (EP,US); C07D211/72 (EP,US); C07D211/86 (EP,US); C07D211/98 (EP,US); C07D213/70 (EP,US); C07D213/76 (EP,US); C07D213/77 (EP,US); C07D213/78 (EP,US); C07D233/38 (EP,US); C07D233/52 (EP,US); C07D233/80 (EP,US); C07D239/10 (EP,US); C07D239/18 (EP,US); C07D239/36 (EP,US); C07D241/08 (EP,US); C07D241/18 (EP,US); C07D263/26 (EP,US); C07D263/28 (EP,US); C07D265/08 (EP,US); C07D265/10 (EP,US); C07D265/33 (EP,US); C07D275/02 (EP,US); C07D275/03 (EP,US); C07D275/06 (EP,US); C07D277/18 (EP,US); C07D277/36 (EP,US); C07D277/50 (EP,US); C07D277/54 (EP,US); C07D277/60 (EP,US); C07D277/82 (EP,US); C07D279/02 (EP,US); C07D279/06 (EP,US); C07D279/12 (EP,US); C07D285/10 (EP,US); C07D285/16 (EP,US); C07D309/04 (EP,US); C07D309/28 (EP,US); C07D335/04 (EP,US); C07D401/12 (EP,US); C07D403/12 (EP,US); C07D405/12 (EP,US); C07D409/12 (EP,US); C07D513/10 (EP,US); C07F9/59 (EP,US); C07F9/65583 (EP,US); C07C2601/08 (EP,US); C07C2601/14 (EP,US); Y02A50/30 (EP,US) (-)
Designated contracting states	AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IT, LI, LU, MC, NL, PT, RO, SE, SI, SK, TR [2005/03]
Title	German:	DIKETOHYDRAZINDERIVATVERBINDUNGEN UND ARZNEIMITTEL, DIE DIE VERBINDUNGEN ALS WIRKSTOFF ENTHALTEN	[2005/03]
	English:	DIKETOHYDRAZINE DERIVATIVE COMPOUNDS AND DRUGS CONTAINING THE COMPOUNDS AS THE ACTIVE INGREDIENT	[2005/03]
	French:	COMPOSES DERIVES DE DICETOHYDRAZINE ET MEDICAMENTS CONTENANT CES COMPOSES COMME INGREDIENT ACTIF	[2005/03]
Entry into regional phase	25.10.2004	Translation filed
	25.10.2004	National basic fee paid
	25.10.2004	Search fee paid
	25.10.2004	Designation fee(s) paid
	25.10.2004	Examination fee paid
Examination procedure	16.10.2003	Request for preliminary examination filed International Preliminary Examining Authority: JP
	25.10.2004	Amendment by applicant (claims and/or description)
	25.10.2004	Examination requested [2005/03]
	29.07.2010	Despatch of a communication from the examining division (Time limit: M06)
	08.02.2011	Reply to a communication from the examining division
	06.08.2012	Communication of intention to grant the patent
	04.12.2012	Fee for grant paid
	04.12.2012	Fee for publishing/printing paid
Divisional application(s)	The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is 29.07.2010
Opposition(s)	17.10.2013	No opposition filed within time limit [2013/52]
Fees paid	Renewal fee
	13.04.2005	Renewal fee patent year 03
	17.03.2006	Renewal fee patent year 04
	12.04.2007	Renewal fee patent year 05
	28.03.2008	Renewal fee patent year 06
	16.04.2009	Renewal fee patent year 07
	25.03.2010	Renewal fee patent year 08
	12.04.2011	Renewal fee patent year 09
	28.03.2012	Renewal fee patent year 10
Opt-out from the exclusive Tooltip competence of the Unified Patent Court	See the Register of the Unified Patent Court for opt-out data
	Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition Tooltip	CY	16.01.2013
	EE	16.01.2013
	MC	16.01.2013
	SI	16.01.2013
	SK	16.01.2013
	BG	16.04.2013
	[2014/01]
Former [2013/49]	CY	16.01.2013
	EE	16.01.2013
	SI	16.01.2013
	SK	16.01.2013
	BG	16.04.2013
Former [2013/37]	CY	16.01.2013
	SI	16.01.2013
	BG	16.04.2013
Former [2013/35]	CY	16.01.2013
	BG	16.04.2013
Former [2013/34]	BG	16.04.2013
Documents cited:	Search	[AD]WO9917775 (CEPHALON INC [US]) [AD] 1,5-10,12-18* page 1, line 10 - page 3, line 25; table 2, page 38, example 110 *;
		[PX]WO03013518 (SMITHKLINE BEECHAM CORP [US], et al) [PX] 1,3,5-18 * page 3, lines 25-32; page 7, lines 12-16; page 31, line 23 - page 34, line 25; example 28 *
	International search	[A]WO9917775 (CEPHALON INC [US]);
		[XP]WO03013518 (SMITHKLINE BEECHAM CORP [US], et al)
	by applicant	- CROATIA CHEMICA ACTA, (1978), vol. 51, no. 1, pages 81 - 92

The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.

Legal notice
Terms of use
24.1.24; 34p